Name | APTEKA BIOMEDSERVIS, OOO |
|---|
INN | 5504206024 |
|---|
KPP | 550401001 |
|---|
OGRN | 1085543026106 |
|---|
OKPO | 85345982 |
|---|
Address | 644070, Omskaya Oblast', g. Omsk, ul. Kuybysheva, d. D.62 |
|---|
Phone | 22-02-40 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 46.38.29 | Additional activity | Wholesale trade of other food products, not included in other categories | | 46.45.1 | Additional activity | Wholesale trade of perfumes and cosmetics, except soap | | All types of activities | | 46.46.1 | Additional activity | Wholesale of furniture, carpets and lighting equipment | | 46.46.2 | Additional activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | | 47.29.39 | Additional activity | Retail trade of other food products in specialized stores, not included in other categories | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75.1 | Additional activity | Retail sale of cosmetic and toilet articles in specialised stores |
Registration date | 22.05.2008 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 12 po Omskoy oblasti |
|---|
|
APTEKA BIOMEDSERVIS, OOO (Omsk Oblast; INN 5504206024) was registered on 22 May 2008. The company's authorized capital as of July 1, 2012 was 100000 rub. Type of ownership of APTEKA BIOMEDSERVIS, OOO - Limited liability companies. Form of ownership of APTEKA BIOMEDSERVIS, OOO - Private property. Principal activities of APTEKA BIOMEDSERVIS, OOO: retailing drugs in specialized stores (pharmacies) (47.73), wholesale trade of other food products, not included in other categories (46.38.29), wholesale trade of perfumes and cosmetics, except soap (46.45.1). |
Economic indicators2023
Net profit (RAS) of APTEKA BIOMEDSERVIS, OOO dropped in 2023 4.57 times to 3.16 million RUB from 14.45 million RUB over the same period in 2022, the company informed. Revenue remained in the accounting period at the same level and made up 396.91 million RUB compared to 398.57 million RUB 398.57 million RUB; cost of goods sold grew by 1.12% to 358.22 million RUB from 354.25 million RUB; sales profit fell 2.78 times to 7.23 million RUB from 20.09 million RUB. 2022
Net profit (RAS) of APTEKA BIOMEDSERVIS, OOO grew over 2022 by 26.90% to 14.45 million RUB from 11.39 million RUB over 2021, the company informed. Revenue increased in the accounting period by 9.62% to 398.57 million RUB from 363.57 million RUB over 2021; cost of goods sold grew by 9.39% to 354.25 million RUB from 323.83 million RUB; sales profit went up by 22.70% to 20.09 million RUB from 16.38 million RUB. 2021
Net profit (RAS) of APTEKA BIOMEDSERVIS, OOO dropped in 2021 by 49.93% to 11.39 million RUB from 22.74 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 5.53% to 363.57 million RUB from 384.85 million RUB in 2020; cost of goods sold decreased by 5.14% to 323.83 million RUB from 341.38 million RUB; sales profit fell by 34.59% to 16.38 million RUB from 25.04 million RUB. 2020
Net profit (RAS) of APTEKA BIOMEDSERVIS, OOO made up 22.74 million RUB over 2020 compared to net loss of 2.87 million RUB over 2019, the company informed. Revenue increased in the accounting period by 47.09% to 384.85 million RUB from 261.64 million RUB over 2019; cost of goods sold grew by 40.25% to 341.38 million RUB from 243.41 million RUB; sales profit made up 25.04 million RUB compared to sales loss of 526.00 thousand RUB. 2019
Net loss (RA) of APTEKA BIOMEDSERVIS, OOO made up 2.87 million RUB over 2019 compared to net profit of 6.20 million RUB over 2018, the company informed. Revenue increased in the accounting period by 11.20% to 261.64 million RUB from 235.28 million RUB over 2018; cost of goods sold grew by 15.69% to 243.41 million RUB from 210.40 million RUB; sales loss made up 526.00 thousand RUB compared to sales profit of 7.76 million RUB. 2018
Net profit (RAS) of APTEKA BIOMEDSERVIS, OOO dropped in 2018 2.08 times to 6.20 million RUB from 12.90 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 5.26% to 235.28 million RUB from 248.34 million RUB in 2017; cost of goods sold decreased by 4.17% to 210.40 million RUB from 219.56 million RUB; sales profit fell by 46.97% to 7.76 million RUB from 14.62 million RUB. 2017
Net profit (RAS) of APTEKA BIOMEDSERVIS, OOO dropped in 2017 by 23.71% to 9.90 million RUB from 12.98 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 5.38% to 248.34 million RUB from 262.47 million RUB in 2016; cost of goods sold decreased by 6.45% to 219.56 million RUB from 234.69 million RUB; sales profit fell by 19.66% to 11.62 million RUB from 14.47 million RUB. 2016
Net profit (RAS) of APTEKA BIOMEDSERVIS, OOO grew over 2016 by 4.08% to 12.98 million RUB from 12.47 million RUB over 2015, the company informed. Revenue increased in the accounting period by 9.70% to 262.47 million RUB from 239.25 million RUB over 2015; cost of goods sold grew by 8.46% to 234.69 million RUB from 216.39 million RUB; sales profit went up by 13.84% to 14.47 million RUB from 12.71 million RUB. 2014
Net profit (RAS) of APTEKA BIOMEDSERVIS, OOO dropped in 2014 by 27.99% to 7.61 million RUB from 10.57 million RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 24.01% to 173.86 million RUB from 140.19 million RUB over 2013; cost of goods sold grew by 26.54% to 157.13 million RUB from 124.18 million RUB; sales profit fell by 23.69% to 7.61 million RUB from 9.97 million RUB. 2013
Net profit (RAS) of APTEKA BIOMEDSERVIS, OOO grew over 2013 by 4.16% to 10.57 million RUB from 10.15 million RUB over 2012, the company informed. Revenue increased in the accounting period by 3.84% to 140.19 million RUB from 135.01 million RUB over 2012; cost of goods sold grew by 3.45% to 124.18 million RUB from 120.04 million RUB; sales profit fell by 4.00% to 9.97 million RUB from 10.39 million RUB. 2012
Net profit (RAS) of Apteka Biomedservis, OOO grew over 2012 by 14.54% to 10.15 million RUB from 8.86 million RUB over 2011, the company informed. Revenue increased in the accounting period by 33.32% to 135.01 million RUB from 101.27 million RUB over 2011; cost of goods sold grew by 35.16% to 124.63 million RUB from 92.20 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|